Key Facts

PIPS Key Facts
Active Substance
Active Substance:
  • Autologous selected renal cells
Invented Name
Not available at present
PIP Number MHRA-100339-PIP01-21
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Suspension for injection
Therapeutic area
Therapeutic area:
  • Uro-Nephrology
Conditions / Indications
Conditions / Indications:
  • Treatment of Chronic Kidney Disease
Route(s) of administration
Route(s) of administration:
  • Percutaneous use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Autologous selected renal cells.pdf
Published Date 04/05/2022